United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 13, 2026 · Filed Oct 14, 2026

On Oct 13, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$545.52 for US$5.18M under a trading plan, leaving 324,443 shares. Filed Oct 14, 2026 (Form 4).

Sold
9,500 shares
Price
US$545.52 average (US$542.76 to US$551.49)
Value
US$5.18M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 13, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 13, 2026Common StockSale639US$542.76333,304Indirect
Oct 13, 2026Common StockSale2,340US$543.48330,964Indirect
Oct 13, 2026Common StockSale1,492US$544.56329,472Indirect
Oct 13, 2026Common StockSale1,507US$545.52327,965Indirect
Oct 13, 2026Common StockSale1,452US$546.46326,513Indirect
Oct 13, 2026Common StockSale630US$547.47325,883Indirect
Oct 13, 2026Common StockSale698US$548.49325,185Indirect
Oct 13, 2026Common StockSale502US$549.47324,683Indirect
Oct 13, 2026Common StockSale160US$550.59324,523Indirect
Oct 13, 2026Common StockSale80US$551.49324,443Indirect

Source

View original at SEC

Related